Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

BelgiumBack to Belgium

Clinical trials in Herstal

3 clinical trials in Herstal, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Herstal at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Herstal

Open in trial search

Dermatitis atopic

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Herstal

What the registry says about research in the country

01 Herstal
Immune System Diseases
Clinical research in Herstal is focused on immune system diseases, with all currently listed studies centered on atopic dermatitis. These trials are examining whether a new treatment approach can better control symptoms and improve everyday skin health for people living with moderate-to-severe disease. Testing a new therapy for better control of atopic dermatitis Comparing treatment effectiveness against placebo Assessing improvements in skin signs and symptom severity The research program in this Belgian city is aimed at understanding how well treatment options work for patients who need stronger support than standard care alone.
Atopic Dermatitis
The main disease under study is atopic dermatitis, a chronic inflammatory skin condition that can cause itching, redness, and discomfort. Current trials are looking at whether a targeted therapy can offer meaningful relief, either on its own or alongside common skin treatments. Evaluating a new option for moderate-to-severe atopic dermatitis Studying treatment used with topical corticosteroids and topical calcineurin inhibitors Measuring changes in disease control and visible skin improvement Supportive research for patients seeking better symptom management These studies are designed to help clarify whether newer approaches can improve outcomes for people whose skin disease remains difficult to manage.
Topical Combination Treatment Research
Another important area of research is the use of topical corticosteroids and topical calcineurin inhibitors alongside investigational therapy. This work is focused on evaluating how combination treatment may improve relief and disease control compared with standard topical care alone. Studying combination care for moderate-to-severe atopic dermatitis Assessing whether added therapy improves overall response Looking at clinical signs and severity over time The trials in Belgium reflect a practical clinical question: whether pairing new and established treatments can lead to better outcomes for patients.
Therapeutic Innovation in Skin Inflammation
The local trial landscape is small but concentrated, with all active studies exploring a single inflammatory skin condition. This makes Herstal a focused site for research on newer therapies aimed at reducing the burden of persistent eczema symptoms. Exploring a new treatment for inflammatory skin disease Comparing benefit against standard control approaches Helping define better options for routine patient care Overall, the studies are centered on improving treatment effectiveness and expanding options for people living with difficult-to-treat skin inflammation.
Back to BelgiumAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.